Jane Wiesner ([email protected])
Areas of Interest
Dr. Omenn's research focuses on proteo-genomics of cancers and proteomics informatics. He long chaired and remains active in the Human Proteome Organization (HUPO) global Human Proteome Project (www.thehpp.org). There are datasets for application of analytical tools, and there are research teams eager to engage in collaborative studies in the Chromosome-centric HPP and Biology and Disease-driven HPP initiatives. He is a co-founder of the Consortium for Clinical Characterization of Covid-19 using Electronic Health Records (4CE) organized by the i2b2tranSMART Foundation and Harvard colleagues. He has long-standing interests in mechanisms of genetic predispositions to risks from environmental and occupational exposures (eco-genetics) and science-based risk analyses.
Dr. Omenn served as U of M Executive Vice President for Medical Affairs and as Chief Executive Officer of the University of Michigan Health System from 1997-2002. He has been director of the UM-wide Center for Computational Medicine and Bioinformatics since 2005. He is a past president of the American Association for the Advancement of Science and a member of the National Academy of Medicine, the American Academy of Arts & Sciences, and the Association of American Physicians. He serves on the boards of the Hastings Center for Bioethics, the Center for Public Integrity, and the Weizmann Institute of Science.